Bao, S., Zheng, H., Ye, J., Huang, H., Zhou, B., Yao, Q., . . . Chen, R. (2021). Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment. Front Pharmacol.
Citação norma ChicagoBao, Shihui, et al. "Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment." Front Pharmacol 2021.
Citação norma MLABao, Shihui, et al. "Dual Targeting EGFR and STAT3 With Erlotinib and Alantolactone Co-Loaded PLGA Nanoparticles for Pancreatic Cancer Treatment." Front Pharmacol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.